Exosome Sciences

Exosome Sciences Inc., based in Monmouth Junction, NJ, is dedicated to the discovery of exosome-based biomarkers for diagnosing and monitoring Alzheimer's disease, Chronic Traumatic Encephalopathy (CTE), and other neurological disorders in collaboration with Aethlon Medical. The company's TauSome biomarker, which has shown significant promise in identifying CTE in living individuals, has been linked to cognitive decline in former NFL players through recent studies.

With ongoing clinical research and a commitment to advancing understanding of CTE, Exosome Sciences is set to conduct one of the largest studies involving former professional football players at high risk for the disease. Their innovative approach is supported by multiple patent applications, ensuring the protection of their pioneering work in neurological diagnostics.

Generated from the website